• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for glp-1

glp-1

Bodywork: Can weight-loss drugs also treat alcohol and drug addiction?

October 21, 2025

Adam’s Journal GLP-1 drugs like Ozempic, Wegovy and Mounjaro have transformed the field of weight loss. Now I’ve started hearing and reading stories of how the drugs can also curb addiction to alcohol and drugs. Are these just anecdotes, or is there more to it? Dr. Scofield Prescribes Ozempic and its chemical cousins work by […]

Filed Under: Bodywork Tagged With: adam cohen, addiction, addiction help, alcohol addiction, alcohol and drug addiction, dr. hal scofield, drug addiction, glp-1, glp-1 drugs, Hal Scofield, opioid addiction

Bodywork: The benefits of weight-loss drugs beyond weight loss

May 13, 2025

Adam’s Journal Here’s a question from an Oklahoma Medical Research Foundation coworker: I’ve seen articles claiming semaglutides like Ozempic and Wegovy can reduce the risk for a rash of conditions, including dementia and alcohol use disorder. Is it the medicine having this impact, or is it the resulting weight loss? Dr. Scofield Prescribes The class […]

Filed Under: Bodywork Tagged With: adam cohen, dr. hal scofield, glp-1, glp-1 drugs, Hal Scofield, Mounjaro, Ozempic, semaglutides, Wegovy, weight loss, weight loss drugs, weight loss injections, Zepbound

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace